These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17914247

  • 1. Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
    Whaley-Connell A, DeMarco VG, Lastra G, Manrique C, Nistala R, Cooper SA, Westerly B, Hayden MR, Wiedmeyer C, Wei Y, Sowers JR.
    Am J Nephrol; 2008; 28(1):67-75. PubMed ID: 17914247
    [Abstract] [Full Text] [Related]

  • 2. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
    Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, DeMarco VG, Andresen BT, Wei Y, Ferrario C, Sowers JR.
    Hypertension; 2008 Feb; 51(2):474-80. PubMed ID: 18172055
    [Abstract] [Full Text] [Related]

  • 3. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
    Whaley-Connell AT, Chowdhury NA, Hayden MR, Stump CS, Habibi J, Wiedmeyer CE, Gallagher PE, Tallant EA, Cooper SA, Link CD, Ferrario C, Sowers JR.
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
    [Abstract] [Full Text] [Related]

  • 4. Albumin activation of NAD(P)H oxidase activity is mediated via Rac1 in proximal tubule cells.
    Whaley-Connell AT, Morris EM, Rehmer N, Yaghoubian JC, Wei Y, Hayden MR, Habibi J, Stump CS, Sowers JR.
    Am J Nephrol; 2007 Dec; 27(1):15-23. PubMed ID: 17204833
    [Abstract] [Full Text] [Related]

  • 5. [A treatment with rosuvastatin induced a reduction of arterial pressure and a decrease of oxidative stress in spontaneously hypertensive rats].
    Sicard P, Lauzier B, Oudot A, Busseuil D, Collin B, Duvillard L, Moreau D, Vergely C, Rochette L.
    Arch Mal Coeur Vaiss; 2005 Dec; 98(7-8):804-8. PubMed ID: 16220751
    [Abstract] [Full Text] [Related]

  • 6. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
    Manucha W, Kurbán F, Mazzei L, Benardón ME, Bocanegra V, Tosi MR, Vallés P.
    Eur J Pharmacol; 2011 Jan 15; 650(2-3):487-95. PubMed ID: 20940012
    [Abstract] [Full Text] [Related]

  • 7. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK, Mervaala EM, Muller DN, Menne J, Fiebeler A, Luft FC, Haller H.
    J Hypertens; 2009 Mar 15; 27(3):599-605. PubMed ID: 19262227
    [Abstract] [Full Text] [Related]

  • 8. Effect of rosuvastatin on capillary filtration of albumin and blood pressure in rats with streptozotocin-induced diabetes.
    Tarhzaoui K, Valensi P, Boulakia FC, Lestrade R, Albertini JP, Behar A.
    Diabetes Res Clin Pract; 2008 Jun 15; 80(3):335-43. PubMed ID: 18406000
    [Abstract] [Full Text] [Related]

  • 9. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL, Kleinschmidt TL, Davidson EP, Coppey LJ, Lund DD, Yorek MA.
    Vascul Pharmacol; 2008 Jan 15; 48(1):47-53. PubMed ID: 18164667
    [Abstract] [Full Text] [Related]

  • 10. Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation.
    Corna D, Sangalli F, Cattaneo D, Carrara F, Gaspari F, Remuzzi A, Zoja C, Benigni A, Perico N, Remuzzi G.
    Am J Nephrol; 2007 Jan 15; 27(6):630-8. PubMed ID: 17851231
    [Abstract] [Full Text] [Related]

  • 11. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S, Vaquero M, Gómez-Guerrero C, López D, Egido J, Romero R.
    Am J Hypertens; 2005 Apr 15; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
    Verreth W, De Keyzer D, Davey PC, Geeraert B, Mertens A, Herregods MC, Smith G, Desjardins F, Balligand JL, Holvoet P.
    Br J Pharmacol; 2007 Jun 15; 151(3):347-55. PubMed ID: 17384667
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
    Rafikova O, Salah EM, Tofovic SP.
    Metabolism; 2008 Oct 15; 57(10):1434-44. PubMed ID: 18803950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.